Ruben A. Mesa, MD

President, Advocate Health Cancer National Service Line & Executive Director AH Wake Forest Baptist Comprehensive Cancer Center. #MPNs (Tweets-My Opinion)

[Ruben A. Mesa, MD @mpdrc]

Today I join >600 Physicians & Scientists & thousands of team members of @WakeCancer & @LevineCancer joined as one @theNCI Comprehensive Cancer Center - world class cancer care, research & training decreasing cancer burden in the Carolinas & beyond @AtriumHealth @AtriumHealthWFB

[Amer Zeidan عامر زيدان @Dr_AmerZeidan]

We had a fantastic New England Hematologic Disease Symposium #HEHEME 2026 in Bristol, CT, with an outstanding lineup of speaker, lively panel discussions, and a research competition & awards for trainees. Mark calendars for 2027 edition on November 12, 2027 in Hartford, CT.

[OncoDaily @oncodaily]

Discovery Science Driving Progress in Cancer Research - Ruben A. Mesa, MD (@mpdrc)

https://t.co/vi1RP38PMN

[OncoDaily @oncodaily]

Our Teams Have Achieved NFP Pancreas Cancer Center of Excellence Designation - Ruben Mesa

@mpdrc

https://t.co/ysNsFOFnAp

[Ruben A. Mesa, MD @mpdrc]

Deeply honored to have receivedDr. Ali Bilgrami award for Clinical Excellence at the New England Hematologic Diseases Symposium. Inspired by Dr Bilgrami’s legacy. @Dr_AmerZeidan #SyedSaqibAli @AdamBoruchov @Syed_SaqibAli @SudhanshuMulay @wakeforestmed @LevineCancer

[OncoDaily @oncodaily]

What’s Next for Lung Cancer Care at Advocate Health? - Ruben A. Mesa, MD (@mpdrc)

https://t.co/NN4sJu8Tva

[Naveen Pemmaraju, MD @doctorpemm]

👏👏👏I was honored to be invited back to speak at @WeillCornell at the 15th annual Richard T Silver MD International Patient Symposium on MPNs hosted by @GhaithAbuZeinah in honor of the memory of our mentor Dr Silver | #MPNSM @PedsHemeDoc @mpdrc 🙏

[Ruben A. Mesa, MD @mpdrc]

@UChicagoLeuk @DrWendyStock @ASH_hematology Congratulations Wendy!

[OncoDaily @oncodaily]

Margaret Foti (@AACR_CEO) Highlights Ruben Mesa’s (@mpdrc) Impact at AACR’s Cancer Health Disparities Conference

@AACR

https://t.co/2KpN9ci8ET

[IACH @TheIACH]

𝗧𝗵𝗲 𝗠𝗣𝗡𝗖𝗼&𝗗 𝘁𝗿𝗮𝗰𝗸 𝗵𝗮𝗽𝗽𝗲𝗻𝗶𝗻𝗴 𝗻𝗼𝘄 𝗮𝘁 #IACH2026 🇫🇷

𝘗𝘳𝘰𝘧. 𝘊𝘭𝘢𝘪𝘳𝘦 𝘏𝘢𝘳𝘳𝘪𝘴𝘰𝘯 𝘢𝘯𝘥 𝘗𝘳𝘰𝘧. 𝘙𝘶𝘣𝘦𝘯 𝘔𝘦𝘴𝘢 𝘰𝘱𝘦𝘯 𝘵𝘩𝘦 𝘵𝘳𝘢𝘤𝘬, 𝘣𝘳𝘪𝘯𝘨𝘪𝘯𝘨 𝘵𝘰𝘨𝘦𝘵𝘩𝘦𝘳 𝘦𝘹𝘱𝘦𝘳𝘵𝘴 𝘧𝘰𝘳 𝘢𝘯 𝘦𝘹𝘤𝘪𝘵𝘪𝘯𝘨 𝘱𝘳𝘰𝘨𝘳𝘢𝘮 𝘧𝘰𝘤𝘶𝘴𝘦𝘥 𝘰𝘯 𝘮𝘺𝘦𝘭𝘰𝘱𝘳𝘰𝘭𝘪𝘧𝘦𝘳𝘢𝘵𝘪𝘷𝘦 𝘯𝘦𝘰𝘱𝘭𝘢𝘴𝘮𝘴.

𝘍𝘰𝘭𝘭𝘰𝘸 𝘵𝘩𝘦 𝘴𝘦𝘴𝘴𝘪𝘰𝘯𝘴 𝘭𝘪𝘷𝘦, 𝘰𝘯𝘴𝘪𝘵𝘦 𝘰𝘳 𝘰𝘯𝘭𝘪𝘯𝘦⬎
https://t.co/3p6cTE50iA

@Mohty_EBMT @mpdrc @harrisoncn1 Zinkand Werner

[MPN_Hub @MPN_Hub]

CONGRESS | #IACH2026 | PRESENTATION

Ruben Mesa discusses novel agents targeting anemia pathways in #myelofibrosis.

Mesa states that, because anemia in MF is multifactorial, combination therapies targeting complementary pathways may be warranted. He reviews key data supporting current and emerging therapies for anemia management and presents a treatment framework to help guide treatment selection.

Follow our live feed for more updates: https://t.co/jdZfUqQe5a

Intended for HCPs. This congress coverage is independently supported through funding from pharmaceutical companies. A full list of our funders can be found on our website. Funders are allowed no influence.

#MPN #MPNsm #MedEd #MedCongress @TheIACH @mpdrc

[IACH @TheIACH]

❔Expert Q&A with Dr. Ruben Mesa

The search for the "Holy Grail" of anemia treatment.

What therapeutic strategy is bringing us closest to improving anemia management in myelofibrosis?

Watch Dr. Ruben Mesa gives a brief preview of this important topic ahead of the IACH Annual Meeting 2026.

https://t.co/5BEG4bzOmB

@mpdrc @Mohty_EBMT

[OncoDaily @oncodaily]

Advocate Health Comes Together in Pink to Support Cancer Research - Ruben Mesa (@mpdrc)

https://t.co/RoeSBO7bGR

[OncoDaily @oncodaily]

NFL And Carolina Panthers Unite To Raise Cancer Awareness - Ruben Mesa (@mpdrc)

https://t.co/GCx14wd4Pv

[OncoDaily @oncodaily]

Advocate Health Ranks First in the Country in Nursing Excellence Designations - Eugene A. Woods

@BettyJoRocchio @mpdrc @advocatehealth

https://t.co/RQvrwjsW9V

[OncLive.com @OncLive]

What does the @FDA approval of ropeginterferon alfa-2b mean for the essential thrombocythemia treatment paradigm? @mpdrc of @AtriumHealth breaks down the significance.

🎙️Listen now: https://t.co/ONnm7rXnjk

[VJHemOnc @VJHemOnc]

How can we best integrate symptoms and QoL in MPNs?🤔🩸

@mpdrc is on stage right now, sharing insights into this at #iwMDSMPN26!

#MPNsm #HemOnc

[OncoDaily @oncodaily]

How Can Expanded Screening Improve Cancer Prevention and Early Detection? - Ruben Mesa (@mpdrc)

https://t.co/DBqpo7VfOi

[Blood Cancers Today @Blood_Cancers]

The FDA approval of ropeginterferon Alfa-2b marks an ‘important first step’ in essential thrombocythemia, according to Ruben Mesa, MD (@mpdrc) of @AtriumHealthWFB.

💡 Learn more about the approval and results of the SURPASS ET trial.

➡️ https://t.co/q49mVW85c1

[OncoDaily @oncodaily]

Ruben Mesa on the 23rd Annual Brain Tumor Center of Excellence Retreat

@mpdrc

https://t.co/mSvggxupmR

[Oncology Brothers @OncBrothers]

RopegIFN is now ✅ approved for ET based off SURPASS-ET trial. Here we discussed this trial, findings, & clinical implications w/ #DrJohnMascarenhas from @TischCancer

Full 🗣️
⭐️ https://t.co/1GqUoO06Q2
⭐️ “Oncology Brothers” podcast

@OncUpdates #HemeTwitter @OncoAlert #mpnsm